Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates.
Different selection patterns of resistance and cross-resistance to HIV-1 agents targeting CCR5.
High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study.
Human papillomavirus 16 integration and risk factors associated in anal samples of HIV-1 infected men.
New molecular method for the detection of human papillomavirus type 16 integration.
Mild improvement in mitochondrial function after a 3-year antiretroviral treatment interruption despite persistent impairment of mitochondrial DNA content.
IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients.
Minimal removal of raltegravir by hemodialysis in HIV-infected patients with end-stage renal disease.
CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART.
Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trials.